Page last updated: 2024-08-21

hesperidin and Fibrosis

hesperidin has been researched along with Fibrosis in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Amini, N; Badavi, M; Basir, Z; Hajipour, S; Nejaddehbashi, F; Sarkaki, A1
Hashimoto, K; Hashimoto, T; Kariya, T; Koyano, T; Kumrungsee, T; Matsuyama, M; Sakurai, H; Sanada, Y; Sotomaru, Y; van de Loo, FAJ; Yanaka, N; Yazawa, N1
Ding, Y; Fu, X; Liu, F; Lou, Y; Wen, H; Yang, L; Yang, Q; Zhang, J; Zhang, L1
Bian, Z; Cheng, Z; Deng, W; Fang, Y; Jiang, D; Lin, Y; Liu, Y; Pu, P; Tang, Q; Zhang, J; Zhang, R; Zhou, H1
He, Y; Huang, C; Kong, LN; Li, J; Lin, X; Ma, TT; Meng, XM; Wang, QQ1

Other Studies

5 other study(ies) available for hesperidin and Fibrosis

ArticleYear
The renoprotective effects of hesperidin on kidney injury induced by exposure to severe chronic dust storm particulate matter through inhibiting the Smads/TGF-β1 signaling in rat.
    Naunyn-Schmiedeberg's archives of pharmacology, 2023, Volume: 396, Issue:12

    Topics: Animals; Dust; Fibrosis; Hesperidin; Kidney; Kidney Diseases; Male; Particulate Matter; Rats; Rats, Wistar; Transforming Growth Factor beta1

2023
The serum amyloid A3 promoter-driven luciferase reporter mice is a valuable tool to image early renal fibrosis development and shows the therapeutic effect of glucosyl-hesperidin treatment.
    Scientific reports, 2019, 10-01, Volume: 9, Issue:1

    Topics: Animals; CCAAT-Enhancer-Binding Protein-beta; Cell Line; Fibrosis; Flavonoids; Glucosides; Hesperidin; Humans; Kidney; Kidney Diseases; Luciferases; Male; Mice; Mice, Inbred C57BL; Promoter Regions, Genetic; Serum Amyloid A Protein; Transcriptional Activation; Tumor Necrosis Factor-alpha

2019
Neohesperidin inhibits cardiac remodeling induced by Ang II in vivo and in vitro.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 129

    Topics: Angiotensin II; Animals; Cells, Cultured; Disease Models, Animal; Fibrosis; Gene Expression Regulation; Hesperidin; Hypertrophy, Left Ventricular; Inflammation Mediators; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Oxidative Stress; Rats, Sprague-Dawley; Signal Transduction; Ventricular Function, Left; Ventricular Remodeling

2020
Hesperetin protects against cardiac remodelling induced by pressure overload in mice.
    Journal of molecular histology, 2013, Volume: 44, Issue:5

    Topics: Animals; Body Weight; Cardiomegaly; Cardiotonic Agents; Fibrosis; Gene Expression Regulation; Heart; Hesperidin; Male; MAP Kinase Kinase 4; Mice; Mice, Inbred C57BL; Organ Size; Oxidative Stress; Protein Kinase C beta; Protein Kinase C-alpha; Proto-Oncogene Proteins c-akt; Signal Transduction; Smad Proteins; Transforming Growth Factor beta; Ventricular Pressure; Ventricular Remodeling

2013
Hesperetin derivative-7 inhibits PDGF-BB-induced hepatic stellate cell activation and proliferation by targeting Wnt/β-catenin pathway.
    International immunopharmacology, 2015, Volume: 25, Issue:2

    Topics: Actins; Animals; Apoptosis; Becaplermin; Cell Cycle; Cell Line; Cell Proliferation; Cell Survival; Collagen Type I; Collagen Type I, alpha 1 Chain; Fibrosis; Hepatic Stellate Cells; Hesperidin; Liver Diseases; Male; Mice; Proto-Oncogene Proteins c-sis; Wnt Signaling Pathway

2015